numerator glp 1 GLP-1 Drugs and Consumer Preferences: Assessing Market Opportunities for Oklahoma Food Businesses The Evolution of the GLP-1

Furthermore, practitioners encounter various challenges when managing GLP-1 agonist non-responders and patients seeking GLP-1 non-injectable alternatives when first-line treatments prove ineffective

Single-dose metformin enhances bile acid-induced glucagon-like peptide-1 secretion in patients with type 2 diabetes

The study included 16,492 individuals with Type 2 diabetes who had either experienced a cardiovascular incident or were at risk for one, and they were followed for a median duration of 2.1 years

Preliminary program results are promising: ~1,500 clients have enrolled in the program since the program launched in April 2023, including: 61% of commercial employer-sponsored lives 17% of commercial health plan lives ** 67% of members meet smart logic criteria and do not require submission of a PA request 84% of PA requests result in denial, and 72% overall target fill rate *** ~$1B or ~$4.86 PMPM in client savings 3 These drugs are being studied in both weight- and non-weight-related conditions

& Guinney, J